
Maharishi V. Khirodhar
Examiner (ID: 10559, Phone: (571)270-7909 , Office: P/2463 )
| Most Active Art Unit | 2463 |
| Art Unit(s) | 2463, 2416 |
| Total Applications | 881 |
| Issued Applications | 739 |
| Pending Applications | 63 |
| Abandoned Applications | 97 |
Applications
| Application number | Title of the application | Filing Date | Status |
|---|---|---|---|
Array
(
[id] => 17532509
[patent_doc_number] => 20220111118
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-04-14
[patent_title] => METHOD AND APPARATUS FOR TREATING BONE FRACTURES, AND/OR FOR FORTIFYING AND/OR AUGMENTING BONE, INCLUDING THE PROVISION AND USE OF COMPOSITE IMPLANTS, AND NOVEL COMPOSITE STRUCTURES WHICH MAY BE USED FOR MEDICAL AND NON-MEDICAL APPLICATIONS
[patent_app_type] => utility
[patent_app_number] => 17/338274
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 52850
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 122
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17338274
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/338274 | METHOD AND APPARATUS FOR TREATING BONE FRACTURES, AND/OR FOR FORTIFYING AND/OR AUGMENTING BONE, INCLUDING THE PROVISION AND USE OF COMPOSITE IMPLANTS, AND NOVEL COMPOSITE STRUCTURES WHICH MAY BE USED FOR MEDICAL AND NON-MEDICAL APPLICATIONS | Jun 2, 2021 | Abandoned |
Array
(
[id] => 17272749
[patent_doc_number] => 20210378947
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-12-09
[patent_title] => Biodegradable Implant for Sustained Trans-Nasal Delivery of Therapeutic Agents to the Brain
[patent_app_type] => utility
[patent_app_number] => 17/338505
[patent_app_country] => US
[patent_app_date] => 2021-06-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 17140
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 49
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17338505
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/338505 | Biodegradable implant for sustained trans-nasal delivery of therapeutic agents to the brain | Jun 2, 2021 | Issued |
Array
(
[id] => 18573666
[patent_doc_number] => 11730167
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2023-08-22
[patent_title] => Triamine solidification using diacids
[patent_app_type] => utility
[patent_app_number] => 17/303573
[patent_app_country] => US
[patent_app_date] => 2021-06-02
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 13800
[patent_no_of_claims] => 20
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 150
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17303573
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/303573 | Triamine solidification using diacids | Jun 1, 2021 | Issued |
Array
(
[id] => 20300640
[patent_doc_number] => 12446607
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2025-10-21
[patent_title] => Probiotic microcapsule and preparation method thereof
[patent_app_type] => utility
[patent_app_number] => 17/762078
[patent_app_country] => US
[patent_app_date] => 2021-05-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 2
[patent_figures_cnt] => 4
[patent_no_of_words] => 0
[patent_no_of_claims] => 9
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 126
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17762078
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/762078 | Probiotic microcapsule and preparation method thereof | May 30, 2021 | Issued |
Array
(
[id] => 18522761
[patent_doc_number] => 20230233410
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-07-27
[patent_title] => PROCESS FOR MANUFACTURING A COMPRESSED PRODUCT
[patent_app_type] => utility
[patent_app_number] => 17/999925
[patent_app_country] => US
[patent_app_date] => 2021-05-25
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 1670
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -3
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17999925
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/999925 | Process for manufacturing a compressed product | May 24, 2021 | Issued |
Array
(
[id] => 17049814
[patent_doc_number] => 20210259248
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-26
[patent_title] => LIQUID COMPOSITION COMPRISING MEFENTRIFLUCONAZOLE
[patent_app_type] => utility
[patent_app_number] => 17/319417
[patent_app_country] => US
[patent_app_date] => 2021-05-13
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3227
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -1
[patent_words_short_claim] => 27
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17319417
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/319417 | Liquid composition comprising mefentrifluconazole | May 12, 2021 | Issued |
Array
(
[id] => 18869889
[patent_doc_number] => 11857669
[patent_country] => US
[patent_kind] => B2
[patent_issue_date] => 2024-01-02
[patent_title] => Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices
[patent_app_type] => utility
[patent_app_number] => 17/313339
[patent_app_country] => US
[patent_app_date] => 2021-05-06
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 56
[patent_figures_cnt] => 84
[patent_no_of_words] => 135692
[patent_no_of_claims] => 18
[patent_no_of_ind_claims] => 1
[patent_words_short_claim] => 134
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => patent
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17313339
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/313339 | Treatment of a disease of the gastrointestinal tract with a JAK inhibitor and devices | May 5, 2021 | Issued |
Array
(
[id] => 18565772
[patent_doc_number] => 20230256099
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-08-17
[patent_title] => Safe Use of Bile Acids and Their Salts as Enhancers for Nasal Delivery of Pharmaceuticals
[patent_app_type] => utility
[patent_app_number] => 17/917455
[patent_app_country] => US
[patent_app_date] => 2021-05-03
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 38321
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17917455
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/917455 | Safe Use of Bile Acids and Their Salts as Enhancers for Nasal Delivery of Pharmaceuticals | May 2, 2021 | Pending |
Array
(
[id] => 17020790
[patent_doc_number] => 20210244661
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-08-12
[patent_title] => METHOD OF TREATING EPILEPSY
[patent_app_type] => utility
[patent_app_number] => 17/244963
[patent_app_country] => US
[patent_app_date] => 2021-04-30
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 7699
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -31
[patent_words_short_claim] => 86
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17244963
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/244963 | Method of treating epilepsy | Apr 29, 2021 | Issued |
Array
(
[id] => 17183972
[patent_doc_number] => 20210330857
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-28
[patent_title] => ANTIMICROBIAL ADHESIVE COPOLYMER COMPOSITIONS
[patent_app_type] => utility
[patent_app_number] => 17/242241
[patent_app_country] => US
[patent_app_date] => 2021-04-27
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6479
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -13
[patent_words_short_claim] => 44
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17242241
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/242241 | Antimicrobial adhesive copolymer compositions | Apr 26, 2021 | Issued |
Array
(
[id] => 17988918
[patent_doc_number] => 20220354955
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-11-10
[patent_title] => SUSTAINED DELIVERY FORMULATIONS OF RISPERIDONE COMPOUND
[patent_app_type] => utility
[patent_app_number] => 17/237207
[patent_app_country] => US
[patent_app_date] => 2021-04-22
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 42872
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -11
[patent_words_short_claim] => 2
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17237207
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/237207 | Sustained delivery formulations of risperidone compound | Apr 21, 2021 | Issued |
Array
(
[id] => 17140060
[patent_doc_number] => 20210308071
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-10-07
[patent_title] => Treatment method to abort and or reduce the severity of upper respiratory viral illness as well as to prevent upper respiratory viral illness in humans
[patent_app_type] => utility
[patent_app_number] => 17/221838
[patent_app_country] => US
[patent_app_date] => 2021-04-04
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3759
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -10
[patent_words_short_claim] => 35
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17221838
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/221838 | Treatment method to abort and or reduce the severity of upper respiratory viral illness as well as to prevent upper respiratory viral illness in humans | Apr 3, 2021 | Abandoned |
Array
(
[id] => 16976289
[patent_doc_number] => 20210220526
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-22
[patent_title] => BIODEGRADABLE SILK EAR TUBES
[patent_app_type] => utility
[patent_app_number] => 17/220914
[patent_app_country] => US
[patent_app_date] => 2021-04-01
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9463
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 46
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17220914
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/220914 | Biodegradable silk ear tubes | Mar 31, 2021 | Issued |
Array
(
[id] => 16961632
[patent_doc_number] => 20210213131
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => TREATMENT FOR REDUCING ADVERSE EVENTS INCLUDING CHEMOTHERAPY DISCOMFORT AND OTHER CONDITIONS
[patent_app_type] => utility
[patent_app_number] => 17/219701
[patent_app_country] => US
[patent_app_date] => 2021-03-31
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 9198
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -19
[patent_words_short_claim] => 47
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17219701
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/219701 | Treatment for reducing adverse events including chemotherapy discomfort and other conditions | Mar 30, 2021 | Issued |
Array
(
[id] => 16961666
[patent_doc_number] => 20210213165
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-15
[patent_title] => Autologous Bone Graft Substitute Composition
[patent_app_type] => utility
[patent_app_number] => 17/215843
[patent_app_country] => US
[patent_app_date] => 2021-03-29
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 20234
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -23
[patent_words_short_claim] => 131
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17215843
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/215843 | Autologous bone graft substitute composition | Mar 28, 2021 | Issued |
Array
(
[id] => 18296551
[patent_doc_number] => 20230106237
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-06
[patent_title] => COMPOSITION AND PRODUCT THEREOF
[patent_app_type] => utility
[patent_app_number] => 17/915050
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 6496
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -12
[patent_words_short_claim] => 8
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17915050
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/915050 | COMPOSITION AND PRODUCT THEREOF | Mar 25, 2021 | Pending |
Array
(
[id] => 18467029
[patent_doc_number] => 20230201309
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-06-29
[patent_title] => COMPOSITIONS FOR THE TREATMENT OF A RESPIRATORY CONDITION
[patent_app_type] => utility
[patent_app_number] => 17/928271
[patent_app_country] => US
[patent_app_date] => 2021-03-26
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 4489
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -17
[patent_words_short_claim] => 23
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17928271
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/928271 | COMPOSITIONS FOR THE TREATMENT OF A RESPIRATORY CONDITION | Mar 25, 2021 | Abandoned |
Array
(
[id] => 16946626
[patent_doc_number] => 20210205317
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2021-07-08
[patent_title] => SYNERGISTIC NEUTRACEUTICAL FORMULATIONS
[patent_app_type] => utility
[patent_app_number] => 17/210259
[patent_app_country] => US
[patent_app_date] => 2021-03-23
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3845
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -14
[patent_words_short_claim] => 76
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17210259
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/210259 | SYNERGISTIC NEUTRACEUTICAL FORMULATIONS | Mar 22, 2021 | Abandoned |
Array
(
[id] => 18306907
[patent_doc_number] => 20230110807
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2023-04-13
[patent_title] => STRUCTURE REINFORCING MATERIAL
[patent_app_type] => utility
[patent_app_number] => 17/908860
[patent_app_country] => US
[patent_app_date] => 2021-03-19
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 3902
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -5
[patent_words_short_claim] => 66
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17908860
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/908860 | Structure reinforcing material | Mar 18, 2021 | Issued |
Array
(
[id] => 17426766
[patent_doc_number] => 20220054474
[patent_country] => US
[patent_kind] => A1
[patent_issue_date] => 2022-02-24
[patent_title] => PHARMACEUTICAL FORMULATIONS OF A HIF HYDROXYLASE INHIBITOR
[patent_app_type] => utility
[patent_app_number] => 17/198013
[patent_app_country] => US
[patent_app_date] => 2021-03-10
[patent_effective_date] => 0000-00-00
[patent_drawing_sheets_cnt] => 0
[patent_figures_cnt] => 0
[patent_no_of_words] => 14389
[patent_no_of_claims] => 0
[patent_no_of_ind_claims] => -18
[patent_words_short_claim] => 24
[patent_maintenance] => 1
[patent_no_of_assignments] => 0
[patent_current_assignee] =>[type] => publication
[pdf_file] =>[firstpage_image] =>[orig_patent_app_number] => 17198013
[rel_patent_id] =>[rel_patent_doc_number] =>) 17/198013 | PHARMACEUTICAL FORMULATIONS OF A HIF HYDROXYLASE INHIBITOR | Mar 9, 2021 | Abandoned |